Goldman: state pauses may stall 45% of planned US data centre capacity, briefly
Goldman says states set to tighten data centre rules account for 45% of planned US capacity, but expects any pauses to be short-lived.
European stocks opened lower across the board, with Spain and Italy leading losses as risk appetite soured ahead of US midterm elections.
Major European indices have begun the session in the red, with losses spread right across the region. The weak start follows the turnaround selling on Wall Street overnight, which has left broader market sentiment brittle. Spain and Italy are posting the steepest falls, while the DAX and Eurostoxx are also coming under heavy pressure.
At the open, the picture looked like this:
The session shapes up as a difficult one, since European benchmarks must also absorb the late slide in US equities yesterday. Relentless selling gives dip buyers little reassurance, all the more so because political uncertainty in the US around today's midterm elections adds a further reason for caution.
US futures look softer today as well after Apple's earnings failed to enthuse, with S&P 500 futures 0.2% lower and Nasdaq futures flat at present. Attention will focus on whether Apple drags wider tech sentiment into the mud once more later today, and whether any hint of a rebound can survive the hours ahead.
For the moment the mood is uneasy, and European investors are finding it hard to gain a foothold while markets more widely stay unwilling to take on additional risk.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
Goldman says states set to tighten data centre rules account for 45% of planned US capacity, but expects any pauses to be short-lived.
After the Democratic midterm sweep, Fundstrat's Tom Lee expects tech stocks to climb 15%-20% as hedge funds rebuild exposure; data center stocks fell Wednesday.
AstraZeneca reportedly made a $10 billion offer for Rhythm Pharmaceuticals, sending shares up 28% and targeting the obesity and rare disease markets.
The S&P 500 hit an extreme oversold level on Nov. 2 even as 46.8% of its stocks were overbought, a split unseen in 36 years.